Adult-onset obesity observed in mice when gene ubiquitin disrupted Texas and California researchers who disrupted one type of the gene ubiquitin in mice observed neuronal loss of life in the hypothalamus, impaired control of energy stability and adult-onset obesity in the rodents. The scholarly study, which hints at a method to treat neurodegeneration and obesity, is referred to in this week's on the web Early Edition of the Proceedings of the National Academy of Sciences, U info .S.A.D., associate professor in the Section of Pharmacology at The University of Texas Health Science Center at San Antonio.
'Aduro is certainly developing a new-generation platform technology within the rapidly evolving field of malignancy immunotherapy. As the lead program is pancreatic cancer, the platform has a broad range of potential applications.'.. Aduro raises $19.25 million through Series B equity financing Aduro BioTech, a clinical-stage immunotherapy organization, announced today that it has completed its Series B equity financing from a combined mix of current traders and Morningside Ventures, getting the full total capital secured in this round to $19.25 million.